© 2003 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 Oxford University Press
CORRESPONDENCE |
Re: Soy, Isoflavones, and Breast Cancer Risk in Japan
Affiliations of authors: Department of Epidemiology, Harvard School of Public Health, Boston, MA (SF); Department of Epidemiology and Biostatistics, Gunma University School of Health Sciences, Maebashi, Gunma, Japan (KH).
Correspondence to: Shuku Fujimaki, MD, PhD, Department of Epidemiology, Harvard School of Public Health, Kresge Bldg., 677 Huntington Ave., Boston, MA 02115 (e-mail: sfujimak@hsph.harvard.edu)
| The first 10% of the full text of this article appears below. |
The article by Yamamoto et al. (1) provides further evidence that isoflavones may play a role in reducing the risk of breast cancer. We are also conducting a cohort study (Japan Nurses' Health Study) (2), with a baseline population of 39 713, and analyzing the association between phytoestrogen intake and breast cancer
Correspondence about this Article
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2003 95: 1881-1882.